EVH (Evolent Health) EPS (Basic): $-4.76 (TTM As of Mar. 2026)


EVH Evolent Health Inc EVH
60 GF Score
Price $5.04
GF Value $11.05
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Evolent Health EPS (Basic)?

Evolent Health EVH +4.90% 60 EPS (Basic) is $-4.76 as of Mar. 2026. GuruFocus rates EVH with a GF Score™ of 60/100 and a GF Value™ of $11.05 (Possible Value Trap). The stock has 6 warning signs investors should review.

Evolent Health's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $-0.24. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.76.

Evolent Health's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.24. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.76.

Evolent Health's EPS without NRI for the three months ended in Mar. 2026 was $-0.24. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.76.

During the past 12 months, Evolent Health's average EPS without NRIGrowth Rate was -3880.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was -54.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Evolent Health's highest 3-Year average EPS without NRI Growth Rate was 173.70% per year. The lowest was -54.40% per year. And the median was 15.70% per year.


Evolent Health  (NYSE:EVH) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Evolent Health EPS (Basic) Related Terms


Evolent Health EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Evolent Health's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolent Health EPS (Basic) Chart

Evolent Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.44 -0.20 -1.28 -0.81 -5.07

Evolent Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.63 -0.44 -0.24 -3.84 -0.24
EVH
60GF Score
Evolent Health Inc EVH
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolent Health EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Evolent Health's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-534.51-44.891)/114.208
=-5.07

Evolent Health's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-26.632-0)/111.905
=-0.24

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-4.76 mean?
Evolent Health (EVH) has a EPS (Basic) of $-4.76 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Evolent Health and its competitors.
Is Evolent Health's EPS (Basic) too high?
Evolent Health's current EPS (Basic) is $-4.76. Overall, Evolent Health has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's EPS (Basic) compare to NRC and CTEV?
Evolent Health's EPS (Basic) of $-4.76 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Evolent Health and its competitors. Evolent Health's current EPS (Basic) is $-4.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.05, compared to a current price of $5.04 — trading 54.4% below its estimated fair value. The current EPS (Basic) is $-4.76. Evolent Health's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Evolent Health (EVH), the current EPS (Basic) is $-4.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolent Health (EVH) Overvalued in 2026?

Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued. The current stock price of $5.04 is trading 54.4% below its estimated GF Value™ of $11.05. GuruFocus considers Evolent Health to be Possible Value Trap.

Key valuation signals for EVH:

  • EPS (Basic): $-4.76
  • GF Value™: $11.05 vs. price of $5.04 (54.4% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Evolent Health Business Description

Other Exchanges 9EH:Germany
Address 1812 North Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
60GF Score

Get the complete analysis for EVH

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.04
Price
$11.05
GF Value